Author:
Yuan Jia-qi,Wang Shou-man,Tang Li–li,Mao Jie,Wu Yu-hui,Hai Jian,Luo Sha-yang,Ou Hui-ying,Guo Lei,Liao Li-qiu,Huang Jun,Li Yan,Xiao Zhi,Zhang Ke-jing,Luo Na,Chen Fei-yu
Publisher
Springer Science and Business Media LLC
Reference26 articles.
1. Jemal A, Bray F, Center MM et al (2011) Global cancer statistics. CA Cancer J Clin 61:69–90
2. Kaufmann M, von Minckwitz G, Bear HD et al (2007) Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: new perspectives 2006. Ann Oncol 18:1927–1934
3. Kim Kwan Il, Lee Kyung Hee, Kim Tae Ryung et al (2014) Ki67 as a predictor of response to NAC in breast cancer patients. J Breast Cancer 17(1):40–46
4. Kim SI, Sohn J, Koo JS et al (2010) Molecular subtypes and tumor response to NAC in patients with locally advanced breast cancer. Oncology 79:324–330
5. Sandy J, Della-Fiorentina S (2013) Relative dose intensity in early stage breast cancer chemotherapy: a retrospective analysis of incidence, risk factors and outcomes at a south-west Sydney cancer clinic. J Clin Oncol 9(4):365–372